AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05711537 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auricular Acupressure with Vaccaria 600t ear seeds
Description: Auricular Acupressure utilizing vaccaria 600 t ear seeds applied to 5 designated sites to each ear. Both ears will have seeds applied. Participants will be asked if they consent to having their intervention session photographed and audio recorded in collaboration with the BAA press training and intervention fidelity study.
Study NCT05279625 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: exercise training
Description: using either elastic band, dumbbells, treadmill, cycling, machines for 6 months
Study NCT05279625 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: exercise training
Description: using either elastic band, dumbbells, treadmill, cycling, machines for 6 months
Study NCT05025969 — intervention group
Intervention type: OTHER
Intervention: Glioma data collection
Description: Glioma data collection
Study NCT05025969 — intervention group
Intervention type: OTHER
Intervention: Brain metastasis data collection
Description: Brain metastasis data collection
Study NCT06215014 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric handgrip training
Description: Participants will train three days per week at home for 1 month using a reliable and validated digital handgrip dynamometer (DynX, MD System, Inc., Westerville, USA) in a seated position. The isometric handgrip training protocol will consist of four sets (2 for each hand) of two-min sustained contractions starting at 30% of maximum voluntary contraction (MVC) interspersed by 1-min resting periods (a total of 12-min). All training sessions will be remotely supervised via Zoom or phone call by a research team member to ensure compliance with the exercise prescription. Before each training session, MVCs will be re-assessed over three repetitions, each separated by 30-s, to ensure an accurate exercise prescription. The highest value will be used to determine the target intensity of the session
Study NCT05741684 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered Cognitive Behavioral Therapy
Description: iCBT was administered in an unguided fashion without human therapeutic support. Participants were instructed to progress through the eight core modules over an 8-week period. The modules comprised psychoeducational content centered around CBT, aimed at promoting the development of skills such as self-monitoring of emotions, cognitive distancing, cognitive reframing/restructuring, problem-solving, and mindfulness. In the event of technical difficulties during the intervention, participants were able to seek assistance.
Study NCT05741684 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification
Description: The Dot-Probe Paradigm was utilized within the Attention Bias Modification procedure. The training sessions were comprised of 96 trials, which included facial expression photos depicting happiness, neutrality, and sadness, sourced from four male and four female actors. A fixed cross (+) was presented on the computer screen's center for a duration of 500 milliseconds before each stimulus display, followed by the presentation of two images portraying distinct emotional expressions, which persisted for 500 milliseconds. After the disappearance of the images, an arrow appeared in the location where they had been displayed, and participants were instructed to select the arrow that corresponded with the presented arrow. In the ABM procedure, the arrow was consistently presented following the display of a more positive facial expression, such that in the instance of a sad-neutral face pair, the arrow would always appear in the location of the neutral facial expression image.
Study NCT05628428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise to strengthen neck area.
Description: An exercise protocol will be carried out through educational videos. There will be a total of four videos which will pose exercises for two weeks each. These exercises will be done twice a week. A reminder will be sent by email on the days that they must be carried out.
Study NCT05628428 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Information
Description: Information will be provided on neck pain and how exercise is able to help prevent it.
Study NCT05628428 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information
Description: Information will be provided on neck pain and how exercise is able to help prevent it.
Study NCT06229002 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial alternative current stimulation (tACS) at alpha frequency
Description: Single session of tACS
Study NCT06229002 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham stimulation
Description: Single session of tACS sham stimulation
Study NCT06364605 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rehabilitation with the iReach novel multisensory medical device
Description: From the results of Phases 1,2 and 3, in Phase 4 a medical device for spatial and sensorimotor rehabilitation in infants aged 3 to 36 months will be tested and developed.
Study NCT05316675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotretinoin
Description: isotretinoin 13-cis-retinoic acid), derived from vitamin A
Study NCT05508230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyaluronic Nasal Spray
Description: Health care product - nasal application
Study NCT06193265 — intervention group
Intervention type: PROCEDURE
Intervention: Discectomy
Description: Discectomy is total or more often partial intervertebral disc surgical removal
Study NCT05353998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CDS with Sleep Navigation
Description: The Sleep Navigation program will involve 1-3 meetings between the Sleep Navigator (SN) and the participating family. Participants will also complete baseline and post-intervention assessments, and about 10 to 15 caregivers will be randomly invited to participate in an interview on the acceptability and feasibility of the program. The SN will provide: SDB and sleep health psychoeducation using Patient-Family Education handouts and videos that are currently part of usual care practices; Care coordination for scheduling of specialty care referral(s) for clinical SDB evaluation; Problem-solving for family-identified barriers to accessing specialty care; and Motivational interviewing to enhance family engagement, communication, and collaboration with the family's medical team.
Study NCT05353998 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: CDS-only
Description: Participants will complete baseline and post-intervention assessments. Participants will be able to follow-up with their primary care clinician as needed.
Study NCT06579027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SPEED Training
Description: Children will use ride-on toys controlled using their affected arm to navigate through their environment and complete playful theme-based challenges. Children will use their affected UE during navigation to start and stop the toy, move steadily forward and backward, turn to the right and left, perform 180° and 360° turns to either side, and avoid obstacles. Children will complete object-based UE tasks requiring gross and fine motor control at intermediate stops during navigation. Navigational tasks will be progressed by increasing complexity of paths (straight to slalom paths needing more directional changes), spaces (wide to narrow spaces), and precision (obstacle courses and mazes requiring skillful navigation, motor planning, and route finding). Object-based tasks will be progressed in terms of force requirements (small to large forces), range of motion (near to far reaches), precision (manipulation of large to small objects), and speed of movements (slow to fast).
Study NCT04648579 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hillrom
Description: Hillrom Connecta solution will record vital signs in an automated way, without the need for human intervention, and activate TRR activation when at least one criteria is met. The frequency of monitoring vital signs will be defined based on the MEWS score.
Study NCT04648579 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Hospital usual care regarding vital signs collection and TRR activation.
Study NCT06389305 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: peripheral blood lymphocytes
Description: autologous or allogeneic peripheral blood lymphocytes
Study NCT06389305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CIK cell
Description: autologous or allogeneic cytokine-induced killer (CIK) cells
Study NCT06579027 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CRAFT Training
Description: Children will engage in predominantly seated activities based on conventional occupational therapy to promote unimanual and bimanual UE function. Training sessions will be based on playful child-friendly themes (e.g., dinosaurs, space exploration, aquatic theme, etc.) and all training activities will incorporate the session theme. Activities will involve practice of functional gross and fine motor UE movement patterns that children typically use during daily life. Training will emphasize the use of the affected UE in different roles (i.e., stabilizer, mobilizer, and active and passive assist) during warm-up, building, and art-craft activities. The training will be progressed in terms of forces needed, range of motion, precision, and movement speed.
Study NCT05691257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roxadustat
Description: The initial dose of roxadustat was given according to body weight, which was more than 60kg: 100mg (three times a week); Weight less than 60kg: 70mg (three times a week); 2 weeks later, the corresponding indexes were rechecked and medication was adjusted according to hemoglobin. The target is hemoglobin 100-120g/L.~Reference for medication Method: The use of roxadustat is the same as the RCT study of roxadustat in the treatment of anemia and the drug instructions of roxadustat published by N Engl J Med in 2019.
Study NCT05691257 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Recombinant human eythropoietin and/or Iron agents
Description: Other drugs to treat anemia include: Recombinant human eythropoietin (RH-EPO), iron agents (ferrous succinate, polysaccharide iron complex, iron sucrose, etc.)
Study NCT05691257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human eythropoietin and/or Iron agents
Description: Other drugs to treat anemia include: Recombinant human eythropoietin (RH-EPO), iron agents (ferrous succinate, polysaccharide iron complex, iron sucrose, etc.)
Study NCT04802941 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemotherapy by CDSS (MedicBK)
Description: CDSS (MedicBK) captures the patient-specific data required to determine appropriate care decisions from the EMR and then presents relevant data alongside treatment suggestions to clinicians. MedicBK uses algorithms for presenting treatment suggestions framed by guideline-based therapy and personalized personalized evidence-based therapy. MedicBK consists of three main blocks: database, network meta-analysis, and heterogeneity of treatment effects assessment.
Study NCT04802941 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: General practice
Description: General practice
Study NCT06057376 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low-FODMAP diet group (LFD)
Description: Each participant will be following a low-FODMAP diet group for 3 weeks, followed by 3 week break prior to second diet intervention.
Study NCT06057376 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low Sugar diet group (LAS)
Description: Each participant will be following a low added sugar diet group for 3 weeks, after 3 week break.
Study NCT04967235 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Exercise-based Cardiac Rehabilitation Session
Description: This session will be composed of:~I.10 minutes of initial rest in the supine position; II. 15 minutes of warm-up through stretching and global exercises; III. 30 minutes of treadmill aerobic exercise at an intensity of 60-80% of the heart rate reserve for those without diabetes Mellitus and 40-70% of the heart rate reserve for those diagnosed with diabetes mellitus; IV. 1 minute passive recovery in orthostatic position; V. 30 minutes of passive recovery in the supine position.
Study NCT04967235 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dance-based Cardiac Rehabilitation Session
Description: I.10 minutes of initial rest in the supine position; II. 15 minutes of warm-up through stretching and global exercises; III. 30 minutes of dance therapy. The intensity of the choreography will be set at the same range as the conventional exercise-based session. (60-80% of the heart rate reserve for those without diabetes Mellitus and 40-70% of the heart rate reserve for those diagnosed with diabetes mellitus); IV. 1 minute passive recovery in orthostatic position; V. 30 minutes of passive recovery in the supine position.
Study NCT04690595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BAFFR-CAR T cells
Description: First-in-human trial examining the safety and preliminary efficacy of BAFFR-CAR T cells in participants with r/r B-ALL
Study NCT05183165 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patients with Wilson's disease declaring pregnancy,
Description: Blood and urine biological assessment Dietary assessment
Study NCT06223399 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Imaging-based programming
Description: Preferred contact point(s) and settings for DBS programming will be determined based on the visualization of the electrodes in the patient-specific anatomy and the volume of tissue activated (VTA; i.e., the tissue enclosed within an iso-surface of the activation function). This will be determined with help of the software program Brainlab with the GUIDE XT module.
Study NCT06223399 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Threshold assessment-based programming
Description: The preferred contact point(s) and settings for DBS programming will be determined according to current clinical practice. During the threshold assessment, the amount of electrical current needed to generate symptomatic improvement and the amount of electrical current needed to generate adverse-effects are determined for every contact point of both DBS leads by increasing current with 0.5 mA steps from 0 to approximately 5.0 mA. With each step, severity of Parkinson symptoms and presence of possible adverse-effects are assessed. For each side (i.e., left and right), the contact point with the most favorable trade-off between clinical improvement and adverse effects will be used for stimulation.
Study NCT04777864 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decision Aid
Description: In addition to usual care, participants (parents and adolescents) receive the newly developed decision aid prior to their clinic visit(s). Clinicians receive a summary to review and use to help facilitate the decision making process.
Study NCT06236867 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KaleidoscopeGroup
Description: The group consists of 34 people. Pain level was measured during 3 dialysis sessions.In order for the patients in the kaleidoscope group to recognize the device and increase their compliance during the procedure, a practice was performed using the device before the AVF cannulation procedure. Kaleidoscope application was performed during cannulation.
Study NCT06236867 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ice Application Group
Description: The group consists of 34 people. Pain level was measured during 3 dialysis sessions. Before, during and after AVF cannulation, VAS pain scores will be evaluated after cannulation without any intervention.Ice application application was made with non-melting ice molds to the area where the index finger and thumb of the hand with fistula are joined (HOKU point)
Study NCT06236867 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: The group consists of 34 people. Pain level will be measured during 3 dialysis sessions. In the control group, the vital signs of the patients before AVF cannulation will be recorded.
Study NCT05354388 — intervention group
Intervention type: PROCEDURE
Intervention: Resection surgery of gastrointestinal stromal tumor
Description: oral administration of Ripretinib 150 mg QD. Resection of gastrointestinal stromal tumors was performed in patients who achieved PR or SD
Study NCT05773118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: orthokeratology lens
Description: Subjects will wear orthokeratology lens at night. Axial length elongation over a period of 12-month will be recorded.
Study NCT05773118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: multifocal soft contact lens
Description: Subjects will wear multifocal soft contact lens during the day time. Axial length elongation over a period of 12-month will be recorded.
Study NCT05773118 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Single vision spectacles
Description: Subjects will wear single vision spectacles during the day. Axial length elongation over a period of 12-month will be recorded.
Study NCT05841355 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Educate
Description: Education sessions
Study NCT05841355 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Empower
Description: Empowerment sessions
Study NCT06472817 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT05608564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Piperacillin and Tazobactam in gel form
Description: After non-surgical periodontal treatment, the test group will receive local antibiotics.
Study NCT05608564 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin and Metronidazole
Description: After non-surgical periodontal treatment, the control group will receive systemic antibiotics.
Study NCT06179966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dance group
Description: The application will be taught to the participants' spouses by the researcher after they are admitted to labor, and the spouses will be asked to do it to the participants at regular intervals.
Study NCT06179966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Massage group
Description: After admission to travaya, the researcher will teach the pregnant woman's husband practically and the spouses will massage the participants' backs at certain intervals.
Study NCT05899842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Protein pump inhibitor therapy systematically
Description: Lansoprazole 30mg once per day
Study NCT06457828 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-corticosteroid injection
Description: no infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.
Study NCT06457828 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Non-corticosteroid injection
Description: no infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.
Study NCT06457828 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid injection
Description: infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.
Study NCT06457828 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Corticosteroid injection
Description: infiltration injection of 0.7 ml of dexamethasone lateral to the involved tooth after anesthesia administration.
Study NCT05390970 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Platelet-rich plasma injection
Description: Injection of autologous platelet-rich plasma into the anterior vaginal wall
Study NCT05390970 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Description: Injection of autologous platelet-rich plasma into the anterior vaginal wall
Study NCT05025176 — intervention group
Intervention type: DEVICE
Intervention: Non invasive arterial pressure monitoring
Description: Non invasive arterial pressure monitoring
Study NCT05416021 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dapivirine
Description: dapivirine vaginal ring
Study NCT06196255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-FcRL5 CAR-T
Description: anti-FcRL5 autologous CAR T cells will be infused at a dose ranging from 1 - 2 x 10\^6/kg CAR+ T cells after receiving lymphodepleting chemotherapy.
Study NCT05856773 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Proton Therapy
Description: Pencil Beam Scanning (PBS)
Study NCT05856773 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Proton Therapy
Description: Pencil Beam Scanning (PBS)
Study NCT05025644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pre and post-CPB Drug: Dobutamine Hydrochloride
Description: * Pre-CPB provocation test with DBT stress test will be started (starting at 5 mcg/kg/min, increasing every 3 min, to 10, 15 and 20 mcg/kg/min) until a PG ≥ 50mmHg is achieved (DBT peak dose). The DBT peak dose (DBT-pd) will be recorded.~* Post-CPB provocation test at the DBT-pd achieved preoperatively.
Study NCT05025644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Post-CPB Drug: Dobutamine Hydrochloride
Description: * Pre-CPB no intervention will be required.~* Post-CPB provocation test with DBT stress test will be started (starting at 5 mcg/kg/min, increasing every 3 min, to 10, 15 and 20 mcg/kg/min) or until postoperative provocable PG is >16 mmHg.